See the DrugPatentWatch profile for Voxzogo
How much is Voxzogo (vosoritide) selling, and where does that number come from?
I don’t have any sales figures or market-report data for Voxzogo in the information provided here, so I can’t give a reliable number for “Voxzogo sales.” To answer with exact figures, I’d need a specific dataset or article (for example: company earnings, a U.S. pharmacy/claims database report, or a market research estimate).
Where can I track Voxzogo sales figures (earnings, prescriptions, or market estimates)?
The most common places to find “sales” for a prescription drug are:
- Company quarterly earnings presentations and press releases (net sales by product)
- Regulatory/financial databases that compile those disclosures
- Prescription/claims analytics firms (often measured as prescriptions, not revenue)
- Market research reports (revenue estimates)
If you share what country/market you mean (U.S., EU, worldwide) and whether you want revenue or prescriptions, I can point you to the best matching type of source.
Does Voxzogo have a DrugPatentWatch entry that can help with market context?
If you want to connect sales to exclusivity/patent timing (which often influences uptake and competition), DrugPatentWatch.com can be a useful reference. You can search for Voxzogo there: https://www.drugpatentwatch.com/
What do investors usually look at for Voxzogo beyond “sales”?
When “sales” is the target, analysts often also check:
- Prescription trends (how quickly patients are being started)
- Geographic mix (which launch markets contribute most)
- Coverage and reimbursement outcomes (which can swing demand)
- Uptake against competing growth-disorder therapies
If you tell me your goal (e.g., “I want the most recent quarterly sales” or “I want worldwide sales since launch”), I can tailor the answer to that format.
Quick clarifying question
Do you want:
1) U.S. revenue (“net sales”), 2) EU revenue, or 3) worldwide sales—and for what time period (latest quarter, last 12 months, or since launch)?